Skip to main content

Monitoring radiographic brain tumor progression.

Publication ,  Journal Article
Mehta, AI; Kanaly, CW; Friedman, AH; Bigner, DD; Sampson, JH
Published in: Toxins (Basel)
March 2011

Determining radiographic progression in primary malignant brain tumors has posed a significant challenge to the neuroncology community. Glioblastoma multiforme (GBM, WHO Grade IV) through its inherent heterogeneous enhancement, growth patterns, and irregular nature has been difficult to assess for progression. Our ability to detect tumor progression radiographically remains inadequate. Despite the advanced imaging techniques, detecting tumor progression continues to be a clinical challenge. Here we review the different criteria used to detect tumor progression, and highlight the inherent challenges with detection of progression.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Toxins (Basel)

DOI

EISSN

2072-6651

Publication Date

March 2011

Volume

3

Issue

3

Start / End Page

191 / 200

Location

Switzerland

Related Subject Headings

  • Radiographic Image Enhancement
  • Magnetic Resonance Imaging
  • Humans
  • Glioblastoma
  • Disease Progression
  • Brain Neoplasms
  • 3214 Pharmacology and pharmaceutical sciences
  • 1115 Pharmacology and Pharmaceutical Sciences
  • 0601 Biochemistry and Cell Biology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Mehta, A. I., Kanaly, C. W., Friedman, A. H., Bigner, D. D., & Sampson, J. H. (2011). Monitoring radiographic brain tumor progression. Toxins (Basel), 3(3), 191–200. https://doi.org/10.3390/toxins3030191
Mehta, Ankit I., Charles W. Kanaly, Allan H. Friedman, Darell D. Bigner, and John H. Sampson. “Monitoring radiographic brain tumor progression.Toxins (Basel) 3, no. 3 (March 2011): 191–200. https://doi.org/10.3390/toxins3030191.
Mehta AI, Kanaly CW, Friedman AH, Bigner DD, Sampson JH. Monitoring radiographic brain tumor progression. Toxins (Basel). 2011 Mar;3(3):191–200.
Mehta, Ankit I., et al. “Monitoring radiographic brain tumor progression.Toxins (Basel), vol. 3, no. 3, Mar. 2011, pp. 191–200. Pubmed, doi:10.3390/toxins3030191.
Mehta AI, Kanaly CW, Friedman AH, Bigner DD, Sampson JH. Monitoring radiographic brain tumor progression. Toxins (Basel). 2011 Mar;3(3):191–200.

Published In

Toxins (Basel)

DOI

EISSN

2072-6651

Publication Date

March 2011

Volume

3

Issue

3

Start / End Page

191 / 200

Location

Switzerland

Related Subject Headings

  • Radiographic Image Enhancement
  • Magnetic Resonance Imaging
  • Humans
  • Glioblastoma
  • Disease Progression
  • Brain Neoplasms
  • 3214 Pharmacology and pharmaceutical sciences
  • 1115 Pharmacology and Pharmaceutical Sciences
  • 0601 Biochemistry and Cell Biology